HPV primary screening / cervical screening
Overview
Cervical cancer is one of the most preventable cancers. Early detection of persistent HPV infections through HPV Primary Screening, in addition to HPV vaccination efforts, is intended to help the country meet its goal of eliminating cervical cancer.
From 12 September 2023, this HPV primary screening service (regardless of whether an HPV self-test/clinician assisted test or cervical sample is taken) is intended to help reduce inequalities in health outcomes and to addresses coverage disparities by removing the cost barrier with adequate funding to ensure HPV primary screening is provided at no cost to the identified group of women (priority women).
Follow-up testing is fully funded for everyone, regardless of their eligibility for fully funded routine screening. All eligible follow-up tests are listed below in 'Who is eligible for the service?'.
Your Pinnacle Services Contract applies to this service. By claiming for this service, you have indicated that you have read and agreed to the business rules set out here.
This is NOT a clinical guideline.
